Bionure

MainImage

1,200,196.70€

Out of 960,000.00€

investors

296

Est. ROI

1400%

days left

--

BN201: Primer fármaco de la historia Neuroprotector y Regenerador de la Mielina para tratar la Esclerosis Múltiple

Finish date: 31/03/2017 Barcelona

Premoney valuation

9,400,000.00€

Percentage offered

9.27%

Est. ROI

1400%

Exit horizon

2019

Understand the risks associated with your investments, review all project documentation and ask any questions you have. We will be happy to assist.